{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Comparator+B&page=2", "query": { "intervention": "Active Comparator B", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Active+Comparator+B&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-29T14:36:51.985Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00864344", "title": "A Relative Bioavailability Study of Sertraline HCl 100 mg Tablets Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Sertraline HCl 100 mg tablets, single dose", "type": "DRUG" }, { "name": "Zoloft® 100 mg tablets, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 30, "start_date": "2004-08", "completion_date": "2004-08", "has_results": false, "last_update_posted_date": "2010-08-16", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00864344" }, { "nct_id": "NCT00865696", "title": "A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Mirtazapine 15 mg tablets, single dose", "type": "DRUG" }, { "name": "REMERON® 15 mg tablets, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2001-09", "completion_date": "2001-09", "has_results": false, "last_update_posted_date": "2010-08-17", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00865696" }, { "nct_id": "NCT00864162", "title": "A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Ramipril10 mg Capsules, single dose", "type": "DRUG" }, { "name": "Atlace® 10 mg capsules, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 40, "start_date": "2004-09", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2010-08-16", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00864162" }, { "nct_id": "NCT05541861", "title": "Safety and Effects of an Investigational COVID-19 Vaccine as Booster in Healthy People", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b2 Bivalent (original/Omicron BA.4/BA.5) 30 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 5 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 10 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 15 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b4 30 mcg", "type": "BIOLOGICAL" }, { "name": "BNT162b2 Monovalent (OMI XBB.1.5) 30 mcg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 383, "start_date": "2022-11-08", "completion_date": "2024-11-22", "has_results": true, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 17, "location_summary": "Tempe, Arizona • Newport Beach, California • San Diego, California + 13 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Milford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05541861" }, { "nct_id": "NCT04629976", "title": "Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Hepatitis B" ], "interventions": [ { "name": "NCO-48 Fumarate 4 mg", "type": "DRUG" }, { "name": "NCO-48 Fumarate 20 mg", "type": "DRUG" }, { "name": "Tenofovir Alafenamide 25 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nucorion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 21, "start_date": "2021-01-12", "completion_date": "2022-12-28", "has_results": false, "last_update_posted_date": "2023-01-04", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 1, "location_summary": "Monterey Park, California", "locations": [ { "city": "Monterey Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04629976" }, { "nct_id": "NCT04885530", "title": "ACTIV-6: COVID-19 Study of Repurposed Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "Ivermectin", "type": "DRUG" }, { "name": "Fluvoxamine", "type": "DRUG" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Susanna Naggie, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 10956, "start_date": "2021-06-08", "completion_date": "2024-04-29", "has_results": true, "last_update_posted_date": "2025-11-17", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 110, "location_summary": "Chandler, Arizona • Gilbert, Arizona • Mesa, Arizona + 96 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04885530" }, { "nct_id": "NCT06707636", "title": "Using Life's Essential 8 in Midlife Black Women", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress", "Self-Efficacy", "Heart Disease Risk Factors", "Depression Symptoms", "Awareness", "Perceived Stress", "Lifestyle Intervention", "Behavior Change" ], "interventions": [ { "name": "Experimental: Black Women's Stress and Wellness (B-SWELL) arm", "type": "BEHAVIORAL" }, { "name": "Active Comparator: Wellness (WE) arm", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "64 Years", "sex": "FEMALE", "summary": "45 Years to 64 Years · Female only" }, "enrollment_count": 42, "start_date": "2024-10-11", "completion_date": "2026-05-31", "has_results": false, "last_update_posted_date": "2026-07-01", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06707636" }, { "nct_id": "NCT04579653", "title": "Pupillometry and Locus Coeruleus Activation (PuLCA)", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Visual Impairment", "Ocular Illness" ], "interventions": [ { "name": "transcutaneous electrical nerve stimulation devices", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "18 Years to 30 Years" }, "enrollment_count": 0, "start_date": "2023-11-22", "completion_date": "2023-11-24", "has_results": false, "last_update_posted_date": "2023-12-19", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04579653" }, { "nct_id": "NCT05304351", "title": "Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Herpes Zoster", "Shingles" ], "interventions": [ { "name": "Amezosvatein Antigen High Dose Arm A", "type": "BIOLOGICAL" }, { "name": "Amezosvatein Antigen Low Dose Arm B", "type": "BIOLOGICAL" }, { "name": "Shingrix", "type": "BIOLOGICAL" }, { "name": "Amezosvatein Adjuvant Dose Arm D", "type": "BIOLOGICAL" }, { "name": "Amezosvatein Adjuvant Dose Arm F", "type": "BIOLOGICAL" }, { "name": "Amezosvatein Adjuvant Dose Arm H", "type": "BIOLOGICAL" }, { "name": "Amezosvatein Adjuvant Dose Arm J", "type": "BIOLOGICAL" }, { "name": "Amezosvatein Adjuvant Dose Arm L", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Curevo Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 1516, "start_date": "2022-02-02", "completion_date": "2032-03-06", "has_results": false, "last_update_posted_date": "2025-09-30", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 14, "location_summary": "Tempe, Arizona • Coral Gables, Florida • Tampa, Florida + 11 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Oak Brook", "state": "Illinois" }, { "city": "Lenexa", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05304351" }, { "nct_id": "NCT02456831", "title": "Soy Formula Feedings in Healthy, Term Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gastrointestinal Tolerance" ], "interventions": [ { "name": "Experimental Infant Formula 1", "type": "OTHER" }, { "name": "Experimental Infant Formula 2", "type": "OTHER" }, { "name": "Experimental Infant Formula 3", "type": "OTHER" }, { "name": "Active Comparator: Control Infant Formula", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Abbott Nutrition", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Weeks", "maximum_age": "9 Weeks", "sex": "ALL", "summary": "2 Weeks to 9 Weeks" }, "enrollment_count": 115, "start_date": "1992-12", "completion_date": "1994-06", "has_results": false, "last_update_posted_date": "2015-05-29", "last_synced_at": "2026-09-29T14:36:51.985Z", "location_count": 7, "location_summary": "Little Rock, Arkansas • Aurora, Illinois • Owensboro, Kentucky + 4 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Aurora", "state": "Illinois" }, { "city": "Owensboro", "state": "Kentucky" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Canton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02456831" } ] }